NCT06066528: A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
- State
- Completed
- Phase
- Phase 3
- People
- 755 taking part
- Started
- 27 Nov 2023
- Primary completion
- 12 Dec 2025
- Arms
- Survodutide 3.6 mg, Survodutide 6.0 mg
- Results
- None posted
- Papers
- doi:10.1056/nejmoa2607219, doi:10.1111/dom.70263
- 4 Oct 2023: Trial registered
- 27 Nov 2023: Trial started
- 1 Apr 2026: Trial completed